Access

News and Views

Nature 419, 795-797 (24 October 2002) | doi:10.1038/419795a

Open Innovation Challenges

naturejobs

Cancer: Pinning a change on p53

Kevin M. Ryan & Karen H. Vousden

Top

An enzyme-induced conformational change is now implicated in activating the p53 protein, one of a cell's prime movers in preventing tumour development.

One in three of us will succumb to cancer at some point in our lives. So it's not surprising that p53, a protein that helps to prevent the development of malignancies, is the subject of intense scrutiny.

  1. Kevin M. Ryan and Karen H. Vousden are at the Beatson Institute for Cancer Research, Cancer Research UK Beatson Laboratories, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK.

Correspondence to: e-mail: Email: k.ryan@beatson.gla.ac.uk; Email: k.vousden@beatson.gla.ac.uk